Four members of collapsin response mediator proteins (CRMPs) are thought to be involved in the semaphorin-induced growth cone collapse during neural development. Here we report the identification of a novel CRMP3-associated protein, designated CRAM for CRMP3-associated molecule, that belongs to the unc-33 gene family. The deduced amino acid sequence reveals that the CRAM gene encodes a protein of 563 amino acids, shows 57% identity with dihydropyrimidinase, and shows 50 -51% identity with CRMPs. CRAM appears to form a large complex composed of CRMP3 and other unidentified proteins in vivo. Indeed, CRAM physically associates with CRMP3 when co-expressed in COS-7 cells. The expression of CRAM is brain-specific, is high in fetal and neonatal rat brain, and decreases to very low levels in adult brain. Moreover, CRAM expression is up-regulated during neuronal differentiation of embryonal carcinoma P19 and PC12 cells. Finally, immunoprecipitation analysis of rat brain extracts shows that CRAM is co-immunoprecipitated with proteins that contain protein-tyrosine kinase activity. Taken together, our results suggest that CRAM, which interacts with CRMP3 and protein-tyrosine kinase(s), is a new member of an emerging family of molecules that potentially mediate signals involved in the guidance and outgrowth of axons.
Neuronal outgrowth and axonal guidance are critical processes that are highly regulated through extracellular signaling (1) . Neuronal outgrowth is directed by attracting and repelling signaling molecules such as netrins (2) and members of the semaphorin protein family (3, 4) . Neuropilin-1 has been identified as a necessary component of a semaphorin III/collapsin-1 receptor that repels dorsal root ganglion axons during development (5) (6) (7) (8) . Most recently, members of the plexin family have been identified as semaphorin receptors (9 -12) . However, much less is known about the intracellular machinery involved in the transduction of these multiple signals leading toward their final cellular response.
Collapsin response mediator proteins (CRMPs) 1 are a family of cytosolic phosphoproteins that are expressed exclusively in the nervous system (13) (14) (15) (16) . Chick CRMP-62 (CRMP2) was first identified by its possible involvement in the semaphorin III/collapsin-1-induced mediation of growth cone collapse in chick dorsal root ganglion neurons (17) . Based on sequence similarity, four CRMP isoforms have been identified in the rat. Certain of these CRMP homologues have also been identified by independent methods as TOAD-64 (13), Ulip (18) , and dihydropyrimidinase (DHPase)-related proteins (DRPs) (15) . Expression pattern studies demonstrated that the expression of rat CRMPs are developmentally regulated and isoform-specific within the nervous system. CRMPs bear sequence similarity to a nematode protein, unc-33, whose absence produces aberrant elongation of axons and uncoordinated Caenorhabditis elegans worm movement (19) . Thus, CRMPs may play a necessary role in the signaling of semaphorin III/collapsin-1-induced growth cone collapse; however, the exact mechanism of CRMP action remains unclear.
In neurons, evidence is accumulating that receptor and nonreceptor protein-tyrosine kinase (PTKs) signaling pathways are essential for axonal outgrowth and guidance during neural development. For instance, Eph receptors have been implicated in axonal pathfinding during the formation of neuronal networks (20) . The molecules that have been analyzed appear to guide axons by repelling the growth cone rather than attracting it. In addition, neurons also express several members of the Src family PTKs including Src, Fyn, Lyn, Yes, and Yrk, which are most abundant and highly enriched in a subcellular fraction of neuronal growth cones (21) .
In contrast, it is interesting to note that until now Syk/ ZAP-70 family PTKs have not been reported to be expressed or play a role in the nervous system. However, in the immune system, Syk/ZAP-70 family PTKs are required for immunoreceptor signaling (22) . These PTKs are characterized by the presence of two tandemly arranged Src homology 2 domains. It has been demonstrated that ZAP-70 plays an essential role in the growth, differentiation, and function of T cells (23) . Previously we have reported that several antibodies (Abs) raised against ZAP-70 showed cross-reactivity with a 66-kDa protein in the developing rat brain (24) . To further characterize this molecule we undertook a large scale purification from rat brain and found that the 66-kDa protein was associated with CRMP3 and another unidentified 62-kDa protein sharing homology with unc-33 gene family. Here we report the identification and characterization of this novel protein, which we have named CRAM for CRMP-associated molecule. We demonstrate that CRAM not only associates with CRMP3 but also with some PTK(s) together with its/their substrate(s), that the expression of CRAM is developmentally regulated in rat brain, and that CRAM may play an important role in neuronal guidance and outgrowth.
EXPERIMENTAL PROCEDURES
Materials-Phenyl-5PW RP was purchased from Tosoh (Tokyo, Japan). Heparin-Sepharose CL-6B, CM-Sepharose, Mono Q, and Mono S columns were from Amersham Pharmacia Biotech. Aprotinin, phenylmethylsulfonyl fluoride (PMSF), protein A-agarose, molecular mass standards, retinoic acid and anti-M2-FLAG Ab were from Sigma. Silver stain kit and lysyl endopeptidase were from Wako (Japan). SD rats were from SLC Inc. (Shizuoka, Japan). Anti-ZAP-70 Ab (raised against a synthetic peptide corresponding to amino acid residues 485-499) and immunizing peptide were from Santa Cruz Biotechnology. Anti-phosphotyrosine monoclonal Ab 4G10 was from Upstate Biotechnology Inc. Universal tyrosine kinase assay kit (MK410) was from TaKaRa (Kyoto, Japan). Anti-CRAM Ab was produced by immunizing a rabbit with synthetic peptide (residues 468 -485). Nerve growth factor (NGF) (7S) was purchased from Chemicon International Inc. Rat tail collagen was from Roche Molecular Biochemicals.
Cell Culture-P19 mouse embryonic carcinoma cells were maintained in ␣-minimal essential medium supplemented with 10% fetal bovine serum at 37°C, in 5% CO 2 , in a humidified chamber. To promote differentiation, cells were first allowed to aggregate in bacterial grade dishes in ␣-minimal essential medium containing 10% fetal bovine serum and 1 M retinoic acid (RA). Two days later, floating aggregates were collected, washed with ␣-minimal essential medium, replated onto bacterial grade Petri dishes and incubated with RA for 2 more days. The aggregates were then dispersed into single cells by treatment with 0.05% trypsin/0.02% EDTA. The cell suspension was then plated onto a 100-mm tissue culture grade dish to induce neural differentiation.
PC12 rat pheochromocytoma cells were maintained on collagencoated dishes in Dulbecco's modified Eagle's medium supplemented with 0.584 g/liter L-glutamine, 10% horse serum, and 5% fetal bovine serum at 37°C as above. To induce differentiation to a neuronal phenotype, PC12 cells were maintained in medium containing 100 ng/ml NGF.
Purification of 66-kDa PTK from Rat Brain-Brains from 20-day-old rats (wet weight, ϳ50 g) were cut into small pieces and homogenized in a blender for 1 min using 5 volumes of cold homogenization buffer (50 mM Tris/HCl, pH 7.5, 0.25 M sucrose, 5 mM EDTA, 10 M sodium orthovanadate, 1 mM PMSF). All subsequent procedures were carried out at 4°C. The homogenate was centrifuged at 8000 ϫ g for 10 min to remove unbroken cells and fatty material, and the supernatant was filtered through glass wool. The filtrate was centrifuged at 100,000 ϫ g for 60 min. The supernatant (200 ml) was passed through CM-Sepharose (20 ml) and applied to a column of heparin-Sepharose CL-6B (20 ml) equilibrated with buffer A (50 mM Tris/HCl, pH 7.5, 10 mM 2-mercaptoethanol, 1 mM EDTA, 10 M sodium orthovanadate, 0.1 mM PMSF). The heparin column was washed with 100 ml of buffer A and eluted with 0.14 M NaCl in buffer A. To the eluate (25 ml) ammonium sulfate was added to adjust the concentration to 0.75 M (NH 4 ) 2 SO 4 and then applied to a Phenyl-5PW RP (5.0 mm, inner diameter ϫ 7.5 cm) column. The Phenyl-5PW RP column was washed with 0.68 M (NH 4 ) 2 SO 4 in buffer A and eluted with 0.4 M (NH 4 ) 2 SO 4 in buffer A. The eluate was concentrated 10-fold by Centriplus 30 (Amicon) and applied to a column of Superdex 200 (1.6 ϫ 60 cm). Fractions (5 ml each) containing a 66-kDa PTK were pooled (total volume, 20 ml), passed through a Mono Q column (1 ml) and applied to a Mono S (1 ml) column equilibrated with buffer A. The Mono S column was washed with buffer A (20 ml), and the protein was eluted with 0.2 M NaCl in buffer A. The eluate (5 ml) was again applied to a column of Superdex 200 (1.6 ϫ 60 cm), and fractions (1 ml each) containing a 66-kDa PTK were pooled as a final preparation (5 ml).
Determination of Internal Peptide Sequence of Purified 60 -70-kDa Proteins-Polyacrylamide gel slice containing 60 -70-kDa proteins (about 100 pmol) was excised and digested with 3 g of lysyl endopeptidase at 37°C overnight in 100 l of 20 mM NH 4 HCO 3 , 10% (v/v) acetonitrile, and 0.1% (v/v) Triton X-100. The peptides were separated with a Perkin-Elmer-Applied Biosystems model 173A liquid chromatography system (Foster City, CA, USA) and then analyzed with a Perkin-Elmer-Applied Biosystems model 492 automated amino acid sequencer.
Cloning of Rat CRAM Full-length cDNA-Deduced nucleic acid sequences from the three different unknown peptide fragments obtained by internal peptide sequencing (Table I) were used as probes to screen a ZAP II cDNA library from 3-week-old rat brains (Stratagene). This screening procedure allowed the identification of a unique cDNA clone. The cDNA insert from this unique clone was then sequenced on both strands using forward and reverse primers specific for polylinker edges of the vector by an ABI 377 automated DNA sequencer. Because the insert cDNA was found to be incomplete after sequencing, we performed a 5Ј-rapid amplification of cDNA ends (RACE) technique involving 3-week-old rat brain total RNA as a template, a 3Ј primer (5Ј-ACAT- AGGCGGCTGCAT-3Ј) specific for the previously identified partial sequence, and a 5Ј primer from RACE System, version 2.0 (Life Technologies, Inc.). The 5Ј-RACE polymerase chain reaction was performed under the following conditions: an initial denaturation step at 94°C for 5 min; followed by 35 cycles at 94°C for 30 s, 55°C for 30 s, and 72°C for 2.5 min; and a final elongation step at 72°C for 10 min. The amplified products were separated on 0.8% agarose gels, and DNA fragments were recovered using the Geneclean method from Bio101 for subcloning into the pCR2.1 TA cloning vector (Invitrogen) according to the manufacturer's instructions. Sequencing of both strands of the cloned 5Ј-RACE fragments was performed as described above using an ABI sequencer and primers specific for the cloning vector and revealed Fractions 10 -13 from the SD-200 gel filtration chromatography were pooled, and aliquots of the resulting suspension were immunodepleted by protein A beads conjugated to normal rabbit serum (NRS), anti-ZAP-70 Ab, or anti-ZAP-70 Ab together with a ZAP-70 blocking peptide (1 mM) (as indicated). Supernatants of each sample were subjected to 10% SDS-PAGE followed by silver staining. For the last lane, anti-ZAP-70 Ab immunoprecipitates were recovered, and immunoprecipitated (IP) proteins were eluted using ZAP-70 blocking peptide (1 mM) as a displacement factor; supernatant was then analyzed as previously. C, aliquots of the pooled fractions were incubated in a reaction mixture containing 100 mM Hepes/NaOH, pH 8.0, 10 M Na 3 VO 4 , 50 mM MgCl 2 , 5 mM MnCl 2 , and 50 M ATP for 0 or 10 min at 30°C. The reactions were terminated by boiling for 3 min with SDS-PAGE sample buffer and analyzed by immunoblotting (IB) using an anti-phosphotyrosine Ab (4G10). the full-length cDNA sequence encoding CRAM.
Immunoprecipitation and Immunoblotting Procedures-All procedures were carried out at 4°C. Rat brains were lysed in the lysis buffer (20 mM Tris/HCl, pH 8.0, 1% Nonidet P-40, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 10 g/ml aprotinin, 10 g/ml leupeptin, and 1 mM sodium orthovanadate).The lysates (1 mg) from rat brain or cultured cells were clarified by centrifugation at 100,000 ϫ g for 10 min and immunoprecipitated with appropriate Ab. Immunoprecipitates were washed three times with lysis buffer, washed once with 10 mM Hepes/NaOH, pH 8.0, containing 0.5 M NaCl, and finally washed with 10 mM Hepes/NaOH, pH 8.0. Immunoprecipitates were subjected to either an in vitro kinase assay (see below) or boiled with SDS-PAGE sample buffer for 3 min, separated by SDS-PAGE, and transferred to polyvinylidene difluoride membranes (Immobilon P, Millipore) followed by detection with the appropriate Ab as described previously (25) .
In Vitro Kinase Assay-PTK activities contained in each fraction eluted from various purification steps were determined by a nonradioactive enzyme-linked immunosorbent assay kit (Universal tyrosine kinase assay kit, MK410, TaKaRa). Briefly, immobilized PTK substrate (poly(Glu-Tyr)) on microplate was incubated with each sample in the presence of kinase reacting solution for 30 min at 37°C. Samples were washed four times, blocked with blocking solution, and incubated with anti-phosphotyrosine Ab (PY20) conjugated to horseradish peroxidase. For detection, 3,3Ј,5,5Ј-tetramethylbenzidine was used as a horseradish peroxidase substrate. The optical density was measured at 450 nm, and PTK activities of samples were calculated using a calibration curve prepared from kinase activity of standard solution.
Alternatively, the immunoprecipitates or purified samples from rat brain were incubated in a reaction mixture containing 100 mM Hepes/ NaOH, pH 8.0, 10 M Na 3 VO 4 , 50 mM MgCl 2 , 5 mM MnCl 2 , and 50 M ATP for 0 or 10 min at 30°C. The reactions were terminated by boiling for 3 min with SDS-PAGE sample buffer and analyzed by immunoblotting using anti-phosphotyrosine Ab (4G10).
Northern Blot Analysis-RNA isolations and hybridizations were performed as described previously (26) . Total RNA (20 g) was separated using 1.0% formaldehyde gel, transferred to Hybond-N ϩ membrane and probed with 32 P-labeled rat CRAM cDNA. After washing, membrane was exposed to X-Omat AR film at Ϫ70°C using an intensifying screen.
Interaction of CRAM with CRMP3 in COS-7 Cells-Mouse CRMP3/ DRP4 was tagged with FLAG epitope at the N terminus. COS-7 cells transiently transfected with pCMV5 expression vector(s) containing CRAM cDNA and/or FLAG-tagged CRMP3/DRP4 cDNA were lysed in the lysis buffer as described above. The lysates (1 mg) were immunoprecipitated either with anti-FLAG or with anti-CRAM Ab, and the precipitates were immunoblotted with the anti-CRAM or anti-FLAG Ab, respectively.
Immunofluorescence Microscopy-COS-7 cells transiently co-expressing CRAM and FLAG-CRMP3 were fixed with 4% paraformaldehyde in PBS for 10 min, washed twice with PBS, permeabilized with 0.2% Triton X-100 in PBS for 10 min, washed three times with PBS, and blocked with 3% bovine serum albumin in PBS, all at room temperature. For double staining, the cells were incubated with the polyclonal anti-CRAM (diluted 1:200) and the monoclonal anti-FLAG Ab (diluted 1:200) for 2 h at room temperature, washed three times with 0.2% Triton X-100 in PBS, and then washed with fluorescein isothiocyanatelabeled goat anti-rabbit IgG (diluted 1:250) and Cy3-labeled goat antimouse IgG (diluted 1:250) for 1 h. The samples were washed as before, mounted using SlowFade-Light (Molecular Probes), and analyzed using an Olympus (epi)fluorescence microscope.
Preparation of Cytosolic and Membrane Fractions-COS-7 cells or neonatal rat brains were suspended in 10 volumes of cold homogenization buffer (50 mM Tris/HCl, pH 7.5, 0.25 M sucrose, 5 mM EDTA, 10 M sodium orthovanadate, 1 mM PMSF) and homogenized in a blender for 1 min. The homogenate was centrifuged at 8,000 ϫ g for 10 min to remove unbroken cells and fatty material and then centrifuged at 100,000 ϫ g for 60 min. The supernatant was used as the cytosolic fraction. The pellets were lysed with 1 ml of lysis buffer as described above and used as the membrane fraction. The membrane fraction lysate was further clarified by centrifugation at 100,000 ϫ g for 30 min before immunoprecipitation and PTK assay.
RESULTS

Purification of a 66-kDa PTK Cross-reacting with Anti-ZAP-70
Ab from Rat Brains-We have previously reported that a 66-kDa protein from 3-week-old rat brain lysates was specifically cross-reactive with anti-ZAP-70 Ab. This Ab was raised against a synthetic peptide corresponding to ZAP-70 amino acid 485-499, and the Ab recognition was completely blocked in the presence of peptide antigen (Ref. 24 and Fig. 1A ). An immunoprecipitation assay revealed that the immunoprecipitated 66-kDa protein was associated with PTK activity that was able to phosphorylate 66-kDa protein (Ref. 24 and Fig. 1B ). The lower band in Fig. 1B is a nonspecifically recognized immunoglobulin heavy-chain derived from rabbit serum. This result suggested that the 66-kDa protein may be identical to ZAP-70 or closely related to ZAP-70 PTK expressed in the central nervous system, although it is unclear whether the 66-kDa band represents a PTK substrate or a PTK that might undergo autophosphorylation. Because ZAP-70 is highly expressed in tissues of T lymphoid origin and believed to be immune cell-specific, the 66-kDa protein might be a brainspecific ZAP-70-related PTK. In preliminary experiments, we performed reverse transcription-polymerase chain reaction using mRNA prepared from rat brain as template and degenerate polymerase chain reaction primers designed for the conserved amino acid sequences of ZAP-70. We also screened rat brain cDNA library with a ZAP-70 probe under low stringency conditions or using anti-ZAP-70 Ab but were unable to identify a novel ZAP-70-related PTK.
To further examine this 66-kDa PTK, we undertook a large scale purification of the protein from 3-week-old rat brains using its immunological cross-reactivity with anti-ZAP-70 Ab. The purification procedure involved sequential column chromatography on heparin-Sepharose, Phenyl-5PW RP, Superdex-200, Mono Q, and Mono S columns. Protein elution profiles from each step of chromatography were monitored by spectrometry at 280 nm. Proteins contained in the eluate from each chromatographic purification were analyzed using SDS-PAGE, and their ability to react with anti-ZAP-70 Ab was determined by immunoblotting experiments (Fig. 1C) . The final preparation contained at least three major bands with molecular masses of 60 -70 kDa in SDS-PAGE analysis. Gel filtration analysis by Superdex-200 chromatography showed that this 66-kDa PTK migrated as an oligomer of 400 kDa (Fig. 2A) . The elution pattern of PTK activity was highly correlated with the pattern of immunoreactivity to anti-ZAP-70 Ab (Fig. 2A) . Immunodepletion study using binding peptide corresponding to amino acid 485-499 of ZAP-70, and SDS-PAGE analysis revealed that anti-ZAP-70 Ab immunoprecipitated in a specific manner all the proteins contained in the 400-kDa complex and that molecular masses of all these proteins were between 60 -70 kDa, supporting the notion that these proteins interact with each other (Fig. 2B) . These results suggest that this large complex cross-reacting with anti-ZAP-70 Ab contains proteins of only 60 -70 kDa and a PTK activity that could be detected in in vitro kinase assay (Fig. 2C) .
Partial Amino 
Identification of a Novel unc-33 Family Protein
this protein complex, partial amino acid sequence analysis was performed. To this end, polyacrylamide gel slice containing 60 -70-kDa proteins was excised, and peptides were generated by digestion with lysyl endopeptidase, separated by reversedphase high protein liquid chromatography, and subjected to microsequencing as described under "Experimental Procedures." Amino acid sequence analysis revealed seven peptide fragments (Table I) . A homology search using a BLAST data bank of published protein sequences as reference revealed that four peptide fragments matched peptide sequences from the rat CRMP3 protein perfectly (Table I ). The sequences of the three other peptide fragments obtained by peptide sequencing presented no homology with any published rat sequence. However, when compared with the human data base, the unknown peptide sequence 1 (Table I) was found to present a high degree of homology with the human expressed sequence tag clones (ATCC538883). This expressed sequence tag clone was identified from the RNA of four multiple sclerosis lesions from one (Table I ). The underlined region represents the peptide used to generate anti-CRAM Ab. This nucleotide sequence will appear in the DDBJ/EMBL/GenBank TM nucleotide sequence data bases with the accession number AB029432.
patient (male, 46 years) as an unc-33-related protein. Thus, the protein containing peptide sequence 1 may be closely involved in neural degeneration mediated by autoimmune processes. The deduced cDNA sequence from this unknown peptide sequence 1 was used as a probe to screen a ZAP II cDNA library from 3-week-old rat brains. This procedure allowed us to obtain one cDNA clone that, however, upon DNA insert sequencing, (see "Experimental Procedures") did not contain the full-length cDNA. Nevertheless, it did possess over 95% homology with the previously cited human expressed sequence tag clone. To identify the full-length cDNA, we used 5Ј-RACE method using 3-week-old rat brain total RNA as a template, a 3Ј-primer specific for a 16-mer contained in the first incomplete cDNA sequence, and a 5Ј-primer provided with the RACE system (see "Experimental Procedures"). The full-length cDNA obtained by this method presented an open reading frame of 563 amino acid residues (Fig. 3) . Moreover, the deduced amino acid sequence from this open reading frame included the other two unknown peptide sequences (Table I ; indicated with asterisks in Fig. 3) revealed by the sequence analysis of proteins contained in the complex, further supporting the validity of our cloning procedure.
Because this new protein was found to be associated to CRMP3, we have named it CRAM for CRMP3-associated molecule. Based on the cDNA sequence, the deduced molecular mass of CRAM is 61,395 Da, and a theoretical pI of 6.5. The peptide sequence of CRAM underlies a hydrophilic protein presenting several predicted ␣ helices and ␤ sheets. We have also obtained mouse CRAM cDNA using homology sequences and amino acid sequence comparison showed 98.0% homology between the rat and the mouse CRAMs (data not shown).
CRAM, a New Member of the Emerging unc-33 Gene Family-
The amino acid sequence of CRAM showed 57% identity with DHPase and 50 -51% identity with CRMPs (Fig. 4) . A lower degree of amino acid identity was observed between CRAM and C. elegans unc-33 (37%). Like CRMPs, CRAM contained two WD repeat-like amino acid sequences (amino acids 340 -359 and 375-405). Previous report has been implicated in various protein-protein assemblies (30) . Thus, CRAM belongs to the unc-33 gene family. Here we have named CRAM for CRMP-Associated molecule; however, other members of this family have been variously referred to as TOAD-64, CRMP, Ulip, and DRP. Recently, Quinn et al. (27) have proposed a single name, TUC (TOAD/Ulip/CRMP) for this family of proteins. Therefore, the name CRAM may be changed when a general agreement on the nomenclature of this family has been reached.
The amino acid sequence of CRAM displayed consensus sites for PTK (Tyr  471 and Tyr   491 ). Because CRAM was co-purified with PTK activity, CRAM may be one of the direct targets of the associated PTK(s). However, it is unclear whether 66-kDa tyrosine-phosphorylated protein observed in Figs. 1 and 2 ). This is in agreement with in vitro phosphorylation results indicating that the purified recombinant CRAM is a good substrate for protein kinase C (data not shown). Although the significance of CRAM as a protein kinase C substrate is unclear, CRAM may be phosphorylated by these protein serine/ threonine kinases in vivo because CRMP4/Ulip has been identified as a serine/threonine phosphoprotein (18) .
A phylogenetic tree of unc-33-related sequences was constructed based on alignment using the neighbor joining method as shown in Fig. 5 . CRAM sequence shows the greatest similarity with DHPase and divergence from the four CRMPs, indicating that CRAM is more closely related to DHPase than the four CRMPs. Although CRAM contains a metal-binding motif consisting of conserved histidine residues (His 68 and His 70 ) that are required for DHPase activity, we were unable to detect any DHPase activity associated with purified brain CRAM complex and recombinant CRAM expressed in COS-7 cells (data not shown).
CRAM, a Developmentally Regulated Brain-specific Protein-The striking molecular similarity of CRAM with CRMPs and unc-33 protein, which are implicated in the regulation of axonal guidance and neurite outgrowth in C. elegans, led us to investigate their potential biological similarities. The N-terminal partial cDNA sequence from CRAM gene, representing bases 1-800, was used as a probe to study the regulation and distribution of CRAM mRNA expression. Northern blot analysis demonstrated that CRAM is expressed solely in the nervous system, and RNA preparation from various peripheral tissues exhibited no hybridization signal (Fig. 6A) . Several spots seen in liver/intestine are nonspecific. Similar results of CRAM expression pattern were obtained by immunoblot analysis using anti-CRAM Ab to detect CRAM protein in lysates from various tissue extracts (Fig. 6B) . The expression of CRAM mRNA was examined at different stages of rat development (Fig. 6C) . CRAM mRNA becomes detectable in the brain on embryonic day 14, its expression level increasing until postnatal day 1 (P1) and then decreasing to a very low level in the adult brain. Identical results of CRAM expression pattern during rat development were also obtained by immunoblot analysis using anti-CRAM Ab (Fig. 6D) . Densitometric analysis revealed that the protein expression level of CRAM at P1 is about 10-fold higher than that of CRAM at 3 months. Thus, like CRMPs, CRAM expression seems to be developmentally regulated as well.
In an attempt to determine the possible association of CRAM expression with neuronal differentiation, we examined the expression of CRAM in the embryonal carcinoma cell line P19 FIG. 5 . Phylogenetic tree of unc-33 gene family. The relationship among rat CRAM, rat or mouse CRMPs, rat DHPase, and unc-33 were analyzed by both DNASIS (A) and CLUSTAL W program (B). The phylogenetic tree was constructed by the neighbor joining method based on this alignment. Numbers on branches in A are bootstrap percentages supporting a given partitioning. EMBL/GenBank TM accession numbers for rat CRMP1, rat CRMP2 (rat TOAD-64), mouse CRMP3 (mouse Ulip-4), mouse CRMP4 (mouse Ulip-1), rat DHPase, and unc-33 are U52102,Z46882, Y09079, X87817, D63704, and Z14146, respectively. that can be induced to assume a neuronal phenotype. P19 cells are developmentally pluripotent and after exposure to RA develop neuronal properties. Indeed, 6 days of exposure to RA leads approximately 85% of the cells to express neuronal markers (28) . We examined, by Northern blot analysis, CRAM mRNA expression in undifferentiated and RA differentiated P19 cells. As shown in Fig. 7A , prior to the induction of neuronal differentiation, CRAM mRNA expression was very low, but exposure of P19 cells to RA increased CRAM mRNA expression in a time-dependent manner. The maximal level of CRAM mRNA expression was reached 5 days after addition of RA to the culture medium and remained high until the complete neuronal differentiation of cells (7 days of culture). Interestingly, the detection of CRAM expression in P19 cells by immunoblot analysis using anti-CRAM Ab indicated that CRAM protein expression pattern in P19 cells follows the corresponding mRNA expression pattern exactly; the CRAM protein expression was very low in undifferentiated cells and up-regulated by the addition of the differentiation inducer (RA) to the culture medium (Fig. 7B) .
These observations were not limited to P19 cell line. Indeed PC12 cells presented an identical neuronal differentiation-dependent CRAM expression pattern. PC12 cells are an adrenal chromaffin-derived tumor cell line that proliferate but do not assume any neuronal properties under based culture conditions. However, when NGF is added to the culture medium, these cells differentiate into cells presenting neuronal properties including cessation of mitotic activity, neurite extension, and expression of genes usually observed in mature neurons. In the absence of NGF, CRAM protein expression was very low (Fig. 7C ), but exposure of PC12 cells to NGF significantly increased the expression of CRAM protein in cell lysates (Fig. 7C) . Similar results were also obtained by Northern blot analysis detecting CRAM mRNA expression (not shown). FIG. 6 . Northern and Western blot analysis of rat CRAM expression in various rat tissues and the developing nervous system. A and C, total RNA (20 g) from the indicated postnatal day 1 (P1) rat tissues (A) or RNAs from the indicated rat brains at various developmental stages (C) were separated on agarose-formaldehyde gels, transferred onto nylon membranes, and hybridized with 32 P-labeled CRAM cDNA probes. 28 and 18 S RNAs were visualized after staining with ethidium bromide to demonstrate that the equivalent amounts of each sample were loaded onto the gels. The positions of 28 and 18 S ribosomal RNA are shown. B and D, whole lysates (10 g/lane) from the indicated P1 rat tissues (B) or lysates (10 g/lane) from the indicated rat brains at various stages of development (D) were subjected to 10% SDS-PAGE followed by immunoblot (IB) analysis with anti-CRAM Ab. The positions of CRAM mRNA and protein are indicated by arrows. Note that the expression of CRAM is brain-specific and developmentally regulated.
Taken together, these results suggest that the expression of CRAM is not only tissue-specific (expression limited to cells from the nervous system) but also tightly regulated (induced during the differentiation of neurons), further supporting the idea that CRAM may play an essential role in brain development and/or neuronal differentiation.
Association of CRAM with CRMP3 and Unidentified PTK(s)-Because CRAM was found to form a high molecular mass complex containing CRMP3 during the purification process, we next examined whether CRAM could physically associate with CRMP3 when co-expressed in COS-7 cells. As pointedout in Fig. 8A , when lysates of COS-7 cells co-expressing CRAM and FLAG-CRMP3 were immunoprecipitated with the anti-FLAG monoclonal Ab, both CRAM and FLAG-CRMP3 were detected in the CRMP3 immune complex. Similarly, when the same lysates were immunoprecipitated with the anti-CRAM polyclonal Ab, both CRAM and FLAG-CRMP3 were detected in the CRAM immune complex (Fig. 8B) . Neither CRAM nor FLAG-CRMP3 was immunoprecipitated from lysates of COS-7 cells co-expressing CRAM and FLAG-CRMP3 with a control immunoglobulin (data not shown). Subcellular fractionation analysis revealed that both CRAM and FLAG-CRMP3 were localized largely in the cytosolic fraction (Fig. 8C) . Furthermore, double label immunofluorescence microscopy revealed a striking colocalization CRAM and FLAG-CRMP3 (Fig. 8D) . Taken together, these results strongly suggest that CRAM interacts directly with CRMP3 in COS-7 cells.
CRAM was also initially and unexpectedly identified by copurification with a 66-kDa PTK (Fig. 2) . Therefore, we next investigated whether CRAM associated with PTK(s) both by immunoprecipitation and by in vitro kinase assays. Immunoprecipitation of CRAM from rat neonatal brain lysates and in vitro kinase reaction resulted in tyrosine phosphorylation of two proteins of 66 and 95 kDa, as revealed by SDS-PAGE followed by immunoblot analysis with anti-phosphotyrosine Ab (Fig. 9A) . No PTK activity was detected in immunoprecipitates obtained in the presence of 1 mM peptide antigen corresponding to a portion of CRAM (amino acid 468 -485) or in immunoprecipitates using normal rabbit serum (Fig. 9A) . As expected, a 66-kDa protein was also specifically cross-reactive with anti-ZAP-70 Ab (Fig. 9D) . Because the 95-kDa phosphoprotein was not co-purified with 66-kDa protein cross-reactive with anti-ZAP-70 Ab from cytosolic fraction, we next examined whether this 95-kDa protein was derived from membrane fraction. Immunoblot analysis showed that CRAM is localized equally in both particulate and cytosolic fractions of rat neonatal brain (Fig. 9B) , although in COS-7 cell CRAM was largely localized in the cytosolic fraction (Fig. 8C) . Immunoprecipitation of CRAM from cytosolic fraction of rat brain homogenates showed only a 66-kDa tyrosine phosphorylated band, whereas immunoprecipitation from particulate membrane fraction showed a major tyrosine phosphorylated protein of 95 kDa (Fig. 9C ). These results demonstrate that CRAM is associated with two different PTK substrates or PTK themselves, a 95 kDa one in the membrane fraction and another 66-kDa PTK in the cytosolic fraction, and further suggest that PTK(s) may be closely involved in the function and regulation of CRAM and CRMP3.
DISCUSSION
This paper describes the identification, cloning, and characterization of CRAM, a novel protein belonging to unc-33 gene family. An analysis of fetal and adult rat tissues indicated that like CRMPs CRAM is developmentally regulated. The expression of CRAM is brain-specific and high in fetal and neonatal rat brains, when neuronal differentiation and synapse formation are very active, and then declines to a very low level in the adult brain. Furthermore, CRAM expression is up-regulated during neuronal differentiation of embryonal carcinoma P19 cells and PC12 cells. Thus, CRAM is likely to participate uniquely in neural functions during neuronal development. A more extensive analysis using in situ hybridization and immunohistochemistry to map the expression of CRAM throughout the developing brain may provide additional information on the regulation of CRAM gene expression and clues about the function of the gene product. In vivo CRAM forms a large complex with CRMP3 and interacts directly with CRMP3 in a COS-7 cell expression system. In a previous study, Wang and Strittmatter (29) the WD domain has been demonstrated in the formation of ␣ and ␤␥ complex of classical heterotrimeric G proteins (31) . Therefore, these repeats are likely to participate in CRAM-CRMP interaction. Further examination of binding with truncated forms of CRAM and CRMP will identify the regions that are necessary for tight binding. In addition, it should be clarified whether CRAM can associate with CRMPs other than the CRMP3.
Although CRMP2 and unc-33 have been shown to be involved in the nervous system development, the biochemical basis for their function remains to be clarified. The primary structure of CRAM shows a higher degree of sequence similarity to DHPase, a liver enzyme involved in the pyrimidine degradation pathway, than to the four CRMPs. Moreover, CRAM contains a metal-binding motif consisting of conserved histidine residues (His 68 and His 70 ), which is lacking from CRMP. This structural similarity increases the likelihood that CRAM possesses a DHPase-like activity. So far we have been unable to detect any DHPase activity associated with purified brain CRAM complex and recombinant CRAM (data not shown). It is possible that a compound not yet tested does serve as a substrate or co-substrate for CRAM-dependent enzyme activity. A wide range of substrates will be tested in the near future. It is clear at this point that the sequence and structural similarity of CRAM and DHPase warrant further investigation of CRAM interaction with pyrimidine-like molecules. Such investigations are likely to advance our understanding of neuronal growth cone guidance mechanisms.
During the purification of the 66-kDa protein recognized by anti-ZAP-70 Ab, CRAM and CRMP3 were unexpectedly copurified, although we could not identify the PTK associated with the oligomeric complex. Because the level of protein expression of PTK in cells and tissues is generally very small, it is still possible that a small amount of 66-kDa PTK is contained in this complex but at a level undetectable by our current micro-sequencing procedures. The fact that CRAM was associated with PTK(s) raised the possibility that these PTKs may regulate the function of CRAM and CRMPs. Indeed, CRAM has two potential PTK phosphorylation sites at Tyr 471 and Tyr 491 contained in the consensus motif ((R/K)X 2/3 (D/E)X 2/3 Y), suggesting that CRAM may be one of the direct targets of the associated PTK(s). Alternatively, CRAM-associated PTK(s) may play a more extensive role in semaphorin receptor signaling pathway. Indeed, CRMPs have been demonstrated to be crucial components in the downstream signaling pathway of semaphorin receptor. In that context, neuropilin-1, identified as a semaphorin III receptor, was shown to require interaction with additional components, perhaps including PTKs, because the intracellular domain of neuropilin-1 was not required for the transduction of its biological activity (32) . Moreover, studies apart from the nervous system demonstrated that neuropilin-1 is also an isoform-specific receptor for vascular endothelial cell growth factor 165 and signals, in that system, through a receptor PTK, Flt-1 (33), underscoring further the absolute requirement for co-receptors or partners for neuropilin-1 to convey signals across the cell membrane. Most recently plexins, another family of transmembrane proteins distinct from neuropilins, have been identified both in the immune and nervous system as semaphorin receptors (9 -12) . In these studies, plexins were shown to interact directly with neuropilin-1 to form a high affinity receptor for semaphorin, and the intracytoplasmic domain of plexin was absolutely essential for the downstream signaling pathway. Furthermore, evidence was provided that plexins can be phosphorylated on tyrosine residue(s) (12) . However, the intermediary candidates conveying the signals from plexins to CRMPs are still unknown. Therefore, in our hands, the association of CRAM together with CRMP3 and some PTKs, led us to hypothesize that CRAM and PTKs contained in the complex may represent plausible candidates for the downstream signaling pathway of plexin. Further investigations of potential binding affinities between the intracytoplasmic domain of plexin with CRAM-CRMP3-PTK(s) complex will help us to elucidate that question. The most intriguing aspect of semaphorin interpretation lies inside the cell. Studies of growth cone responses to semaphorin III suggest that the disassembly of actin cytoskeleton produces the characteristic collapse (34), but it is not clear how this response is achieved and whether there are other important effects on growth cone cell biology. CRMPs have been identified as candidate transduction components for secreted semaphorins. In addition to CRMPs we have identified CRAM as a new member of unc-33 gene family. The important role of CRAM in neural development is further supported by the finding of its specific expression during neuronal development and its significant association with CRMP3 and PTK(s). The further molecular and biological characterization of CRMPs and CRAM, their regulation, and their potential partners including PTK(s) in cells will provide further clues to their respective biological roles and will contribute to the understanding of the mechanisms underlying the axonal guidance during neuronal development.
